{"gene":"SYT3","run_date":"2026-04-28T21:42:58","timeline":{"discoveries":[{"year":1994,"finding":"SYT3 (Syt3) was identified as a third member of the synaptotagmin family in mouse brain, retaining the characteristic five-domain structure (transmembrane region plus two C2 domains) of other synaptotagmins but with only ~45% amino acid identity to Syt1/Syt2 in the C2 domain. Syt3 is expressed in many regions of the nervous system but not in extraneural tissues, and in PC12 cells it is coexpressed with Syt1 at higher abundance, suggesting individual neurons may express specific synaptotagmin combinations.","method":"cDNA cloning, Northern blot, immunohistochemistry, in situ hybridization","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — original gene identification with expression mapping; single lab, multiple methods","pmids":["8058779"],"is_preprint":false},{"year":1995,"finding":"The first C2 domain of Syt III (but not the C2 domain of Syt IV, VI, or VIII) binds phospholipids in a Ca2+-dependent manner with EC50 = 3–6 µM, similar to Syt I and II. Syt III also binds syntaxin in a Ca2+-dependent manner, but with a lower Ca2+ concentration dependence (<10 µM) than Syt I, II, and V (>200 µM), and all synaptotagmins tested bind clathrin-AP2 with high affinity (Kd = 0.1–1.0 nM).","method":"In vitro phospholipid-binding assay, Ca2+-dependent syntaxin binding assay, clathrin-AP2 binding assay","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — in vitro biochemical reconstitution with quantitative Ca2+ dependence; replicated across multiple synaptotagmin isoforms in same study","pmids":["7791877"],"is_preprint":false},{"year":1999,"finding":"Syt III forms beta-mercaptoethanol-sensitive homodimers and heterodimers with Syt V, VI, and X via three conserved N-terminal cysteine residues (C10, C21, C33 in mouse Syt III). Site-directed mutagenesis showed that the first cysteine (C10) is essential for stable homodimer formation of Syt III, V, and VI, and for heterodimer formation among Syt III, V, VI, and X. Native Syt III from mouse brain also forms these disulfide-linked homodimers.","method":"Site-directed mutagenesis, co-immunoprecipitation, SDS-PAGE under reducing/non-reducing conditions, native brain protein analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with co-IP and native brain validation; single lab but multiple orthogonal methods","pmids":["10531343"],"is_preprint":false},{"year":2007,"finding":"E-Syt3 (extended synaptotagmin-3) is an ER-resident transmembrane protein with three C-terminal C2 domains. Its C2C domain (the most C-terminal C2 domain) functions as a targeting motif directing E-Syt3 to the plasma membrane independently of its transmembrane region. E-Syt2 and E-Syt3 localize to the plasma membrane in transfected cells, unlike E-Syt1 which localizes to intracellular membranes.","method":"Transfection of myc-tagged constructs, immunofluorescence microscopy, domain deletion analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiment with functional domain mapping; single lab","pmids":["17360437"],"is_preprint":false},{"year":2010,"finding":"The crystal structure of Ca2+-bound Syt3 in complex with the SNARE complex was determined and revealed that the Ca2+-binding loops of Syt3 point away from the SNARE complex, suggesting they may interact with the same membrane. This loop arrangement is similar to that inferred from smFRET-derived models of the Syt1-SNARE complex, supporting a conserved mechanism by which synaptotagmin-SNARE interaction aids Ca2+-triggered fusion.","method":"X-ray crystallography (crystal structure of SNARE-induced Ca2+-bound Syt3), single-molecule FRET","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure determination with functional implications; structural data from Syt3 directly cited","pmids":["20173763"],"is_preprint":false},{"year":2011,"finding":"A lipid-binding screen using the C2AB fragment of Syt3 revealed Ca2+-independent lipid interactions mediated via a lysine-rich region of the C2B domain and Ca2+-dependent interactions via the Ca2+-binding loops, consistent with a conserved lipid-binding mechanism shared with Syt1.","method":"Lipid binding screen (protein-lipid overlay and liposome binding assays) with recombinant C2AB fragments, mass spectrometry","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 — direct in vitro lipid binding assay; single lab, single study","pmids":["21928778"],"is_preprint":false},{"year":2013,"finding":"E-Syt2 and E-Syt3 function as ER-PM tethers through C2 domain-dependent interactions with the plasma membrane that require PI(4,5)P2. E-Syts form heteromeric complexes with each other, and through this heterodimerization, E-Syt1 (which also requires elevated cytosolic Ca2+) confers Ca2+ regulation to ER-PM contact formation. E-Syt-dependent contacts are functionally distinct from STIM1/Orai1-mediated contacts and are not required for store-operated Ca2+ entry.","method":"Co-immunoprecipitation, fluorescence microscopy, PI(4,5)P2 manipulation (pharmacological and genetic), Ca2+ imaging, TIRF microscopy","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, replicated across conditions; highly cited foundational study","pmids":["23791178"],"is_preprint":false},{"year":2016,"finding":"E-Syt3 (along with E-Syt1 and E-Syt2) transfers glycerolipids between bilayers in vitro in a Ca2+-dependent manner requiring their SMP domain. Cells lacking all E-Syts show enhanced and sustained accumulation of plasma membrane diacylglycerol following PLC activation (PtdIns(4,5)P2 hydrolysis), demonstrating that E-Syts participate in homeostatic control of PM lipid composition by transferring diacylglycerol from the PM to the ER for metabolic recycling.","method":"In vitro lipid transfer assay, genome-edited E-Syt knockout cells, diacylglycerol imaging (DAG biosensor), rescue experiments with SMP-domain mutants","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro lipid transfer plus KO cell rescue with domain mutagenesis; multiple orthogonal approaches","pmids":["27065097"],"is_preprint":false},{"year":2016,"finding":"Combined inactivation of all three E-Syt genes (E-Syt1, 2, and 3) in mice does not affect viability, fertility, or development under laboratory conditions, but induces compensatory upregulation of Orp5/8, Orai1, STIM1, and TMEM110 genes encoding other ER-PM junction proteins.","method":"Triple knockout mouse generation (insertion/deletion mutations), phenotypic analysis, gene expression analysis","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined phenotypic readout and compensatory gene expression analysis; single lab","pmids":["27399837"],"is_preprint":false},{"year":2017,"finding":"RASSF4 regulates the ER-PM tethering function of E-Syt2 and E-Syt3 by controlling steady-state PM PI(4,5)P2 levels through ARF6-dependent regulation of type I PIP5Ks. RASSF4 knockdown reduces PM PI(4,5)P2, which is required for E-Syt2/3 localization at ER-PM junctions.","method":"siRNA knockdown, PI(4,5)P2 biosensor imaging, TIRF microscopy, RASSF4-ARF6 interaction analysis","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with biosensor imaging; single lab","pmids":["28600435"],"is_preprint":false},{"year":2006,"finding":"SYT3 is the only synaptotagmin expressed in T cells. SYT3 localizes predominantly to multivesicular bodies (not the plasma membrane) where it colocalizes with CXCR4. Knockdown of SYT3 by antisense mRNA or blockade by the isolated C2B domain (which impairs oligomerization) inhibits CXCR4 recycling back to the cell surface, reduces surface CXCR4 levels, and consequently inhibits CXCL12-induced T cell migration and actin polymerization. Overexpression of CXCR4 rescues migration, confirming the mechanism is through receptor recycling.","method":"Antisense mRNA knockdown, C2B domain overexpression, immunofluorescence microscopy, flow cytometry (surface CXCR4), chemotaxis assay, actin polymerization assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — KD with defined phenotypic readout and rescue experiment; single lab, multiple readouts","pmids":["17179206"],"is_preprint":false},{"year":2018,"finding":"Syt3 localizes to postsynaptic endocytic zones in neurons and removes AMPA receptors (specifically GluA2-containing) from synaptic plasma membranes in a Ca2+-dependent manner in response to stimulation. Syt3 knockout abolishes AMPA receptor internalization, long-term depression (LTD), and decay of long-term potentiation (LTP). Disrupting the Syt3:GluA2 interaction using a TAT-GluA2-3Y peptide mimics the Syt3 KO phenotype (lack of LTP decay and lack of forgetting in spatial memory tasks), and these effects are occluded in the Syt3 KO, confirming direct mechanistic linkage.","method":"Syt3 knockout mice, immunofluorescence localization, AMPA receptor internalization assay, LTD and LTP electrophysiology, TAT-GluA2-3Y peptide competition, Morris water maze and spatial memory tasks","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 2 — KO plus peptide competition with occlusion experiment plus multiple behavioral and electrophysiological readouts; single lab but highly rigorous multi-method study","pmids":["30545844"],"is_preprint":false},{"year":2020,"finding":"Hypothalamic E-Syt3 (extended synaptotagmin-3) contributes to diet-induced obesity. Whole-body or POMC neuron-specific ablation of E-Syt3 ameliorates diet-induced obesity, glucose intolerance, and dyslipidemia. Mechanistically, E-Syt3 ablation leads to increased processing of POMC to α-MSH, increased PKC and AP-1 activities, and enhanced expression of prohormone convertases. Conversely, E-Syt3 overexpression in the arcuate nucleus promotes food intake and impairs energy expenditure.","method":"Conditional KO (whole-body and POMC-neuron-specific), AAV-mediated overexpression, Western blot, ELISA, metabolic phenotyping, kinase activity assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO with cell-type specificity and molecular mechanism identified; single lab","pmids":["32747560"],"is_preprint":false},{"year":2021,"finding":"In differentiating adipocytes, E-Syt3 undergoes proteolytic cleavage of its C-terminal C2C domain by a proteasome-dependent multi-step mechanism. Truncated E-Syt3ΔC2C and endogenous E-Syt3 localize to a specialized ER cisterna (termed the 'primordial cisterna') that serves as the birth site of lipid droplets. Knockdown of E-Syt3 inhibits lipid droplet biogenesis in adipocytes.","method":"Confocal microscopy, live-cell time-lapse imaging, proteasome inhibition, siRNA knockdown, electron microscopy, 3D electron tomography","journal":"Traffic (Copenhagen, Denmark)","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization with functional consequence (KD phenotype) and structural imaging; single lab","pmids":["34693607"],"is_preprint":false},{"year":2023,"finding":"Syt3 is upregulated in the penumbra after ischemia/reperfusion injury. Mechanistically, I/R injury augments Syt3-GluA2 interactions, decreases GluA2 surface expression, and promotes formation of Ca2+-permeable AMPA receptors (CP-AMPARs). Syt3 knockout mice are resistant to cerebral ischemia due to high surface GluA2 and low CP-AMPAR levels. Disrupting Syt3-GluA2 binding via TAT-GluA2-3Y peptide promotes recovery from neurological impairments.","method":"Syt3 KO mice, siRNA knockdown/overexpression, co-immunoprecipitation (Syt3-GluA2), surface biotinylation assay, TAT-GluA2-3Y peptide, MCAO model, behavioral testing","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — KO plus co-IP plus peptide disruption with multiple functional readouts; mechanistically orthogonal approaches","pmids":["36892998"],"is_preprint":false},{"year":2025,"finding":"E-Syt3 controls epithelial ion transport by transferring phosphatidylserine (PtdSer) away from ER/PM junction nanodomains, acting antagonistically to ORP5 (which supplies PtdSer). Removal of PtdSer from junctions by E-Syt3 dissociates the cAMP signaling complex, preventing CFTR chloride channel activation and blocking NBCe1-B activation by IRBIT. The C2C domain of E-Syt3 restricts its localization to ER/PM junctions, and lipid transfer activity requires the SMP domain. E-Syt3 depletion in mice improves chloride flux and fluid secretion in salivary glands and pancreatic ducts.","method":"SiRNA knockdown, domain deletion mutants, PtdSer biosensor, co-immunoprecipitation, electrophysiology (CFTR and NBCe1-B currents), mouse gland secretion assays, in vitro lipid transfer","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — lipid transfer reconstitution combined with KD, domain mutagenesis, electrophysiology, and in vivo mouse assays; multiple orthogonal methods","pmids":["40425857"],"is_preprint":false},{"year":2024,"finding":"In zebrafish Mauthner cells, syt3 (ortholog of mammalian SYT3) negatively regulates axon regeneration after spinal cord injury, and this suppression depends on Ca2+ binding by Syt3. MicroRNA-2184 promotes axon regeneration by repressing syt3 expression. Pharmacological stimulation of the cAMP/PKA pathway suggests changes in the readily releasable pool may underlie the Syt3-dependent suppression of regeneration.","method":"Single M-cell miR-2184 overexpression/sponge silencing, syt3 knockdown/overexpression in zebrafish, Ca2+-binding mutant analysis, cAMP/PKA pathway pharmacology, axon regeneration imaging","journal":"Journal of genetics and genomics","confidence":"Medium","confidence_rationale":"Tier 2 — ortholog in zebrafish with Ca2+-binding mutant validation and pharmacological epistasis; single lab","pmids":["38582297"],"is_preprint":false},{"year":2025,"finding":"Syt3 knockout mice exposed to neonatal sevoflurane show exacerbated cognitive impairment, increased neuroinflammation (IL-1β, TNF-α, MCP-1), and increased anxiety-like behavior compared to WT mice. Conversely, CRISPR-mediated Syt3 overexpression in WT mice mitigates sevoflurane-induced cognitive deficits and neuroinflammation. Sevoflurane exposure itself reduces hippocampal Syt3 protein levels in WT mice.","method":"Syt3 KO mice, CRISPR activation overexpression, Western blot/ELISA for Syt3 and inflammatory markers, object location memory, novel object recognition, elevated plus maze","journal":"ACS chemical neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — KO and overexpression with defined behavioral and molecular readouts; single lab","pmids":["40890917"],"is_preprint":false},{"year":2026,"finding":"In EPN neurons projecting to the lateral habenula, Syt3 is highly expressed and selectively co-localizes with VGAT (GABAergic vesicle marker) rather than VGLUT2, and antisense oligonucleotide knockdown of Syt3 increases mIPSC frequency (quantal GABA release probability) without affecting glutamate release, establishing Syt3 as the predominant Ca2+ sensor for GABAergic vesicle fusion at these dual-transmitter terminals.","method":"Confocal 3D reconstruction, antisense oligonucleotide knockdown, whole-cell patch-clamp electrophysiology (mEPSC and mIPSC recording)","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — ASO KD with electrophysiological functional readout; preprint, single lab","pmids":["41959127"],"is_preprint":true}],"current_model":"SYT3 (synaptotagmin-3) is a Ca2+-sensing membrane protein that functions in multiple cellular contexts: in neurons, it acts postsynaptically as a Ca2+-dependent driver of AMPA receptor (GluA2) endocytosis at endocytic zones, thereby mediating LTD, LTP decay, and forgetting, while presynaptically it serves as a Ca2+ sensor for GABAergic vesicle fusion; as an extended synaptotagmin (E-Syt3), it tethers the ER to the plasma membrane via PI(4,5)P2-dependent C2 domain interactions, transfers phosphatidylserine and diacylglycerol between membranes through its SMP domain to maintain PM lipid homeostasis and control epithelial ion transport, and undergoes proteasome-dependent cleavage in adipocytes to support lipid droplet biogenesis; additionally, SYT3 forms disulfide-linked homodimers and heterodimers with other synaptotagmins via conserved N-terminal cysteine residues, and in T cells it localizes to multivesicular bodies where it is required for CXCR4 recycling and chemokine-directed migration."},"narrative":{"teleology":[{"year":1994,"claim":"Identification of Syt3 as a third synaptotagmin family member with the conserved five-domain architecture but distinct brain-region expression patterns established that individual neurons likely deploy specific synaptotagmin combinations.","evidence":"cDNA cloning, Northern blot, immunohistochemistry, and in situ hybridization in mouse brain and PC12 cells","pmids":["8058779"],"confidence":"Medium","gaps":["No functional data; expression pattern alone does not reveal isoform-specific roles"]},{"year":1995,"claim":"Biochemical characterization revealed that Syt3's first C2 domain binds phospholipids and syntaxin in a Ca²⁺-dependent manner (EC₅₀ 3–6 µM), with a lower Ca²⁺ threshold for syntaxin binding than Syt1/2, and that all synaptotagmins bind clathrin-AP2 at nanomolar affinity—establishing Syt3 as a Ca²⁺ sensor with potential roles in both fusion and endocytosis.","evidence":"In vitro phospholipid-binding, syntaxin-binding, and clathrin-AP2 binding assays with purified recombinant domains","pmids":["7791877"],"confidence":"High","gaps":["All data from in vitro assays; cellular context for syntaxin vs. AP2 engagement unknown","Functional consequence of lower Ca²⁺ threshold not tested in cells"]},{"year":1999,"claim":"Discovery that Syt3 forms disulfide-linked homodimers and heterodimers with Syt V/VI/X via conserved N-terminal cysteines (C10 essential) revealed an oligomerization mechanism that could diversify Ca²⁺-sensing complexes.","evidence":"Site-directed mutagenesis, co-immunoprecipitation, non-reducing SDS-PAGE of recombinant and native mouse brain protein","pmids":["10531343"],"confidence":"High","gaps":["Functional significance of homo- vs. heterodimer pools in vivo unknown","Stoichiometry and dynamics of native complexes not resolved"]},{"year":2006,"claim":"SYT3 was identified as the sole synaptotagmin in T cells, localizing to multivesicular bodies where it controls CXCR4 recycling to the surface; its knockdown impaired chemokine-directed migration, broadening Syt3 function beyond neurons to immune cell trafficking.","evidence":"Antisense knockdown, C2B domain overexpression, flow cytometry for surface CXCR4, chemotaxis assay, CXCR4 overexpression rescue in T cells","pmids":["17179206"],"confidence":"Medium","gaps":["Antisense knockdown lacks specificity controls of modern siRNA/KO approaches","Direct physical interaction between Syt3 and CXCR4 not demonstrated","Whether the recycling role is C2 domain Ca²⁺-dependent was not tested"]},{"year":2007,"claim":"Characterization of E-Syt3 as an ER-resident protein whose C2C domain targets it to the PM established a distinct extended-synaptotagmin identity and began to separate E-Syt biology from classical synaptotagmin function.","evidence":"Myc-tagged domain deletion constructs, immunofluorescence microscopy in transfected cells","pmids":["17360437"],"confidence":"Medium","gaps":["Overexpression system; endogenous localization not validated","Lipid-binding specificity of C2C domain not resolved"]},{"year":2010,"claim":"The crystal structure of Ca²⁺-bound Syt3 in complex with the SNARE complex showed that Ca²⁺-binding loops face away from the SNARE bundle, consistent with simultaneous membrane and SNARE engagement—providing a structural framework for Ca²⁺-triggered fusion.","evidence":"X-ray crystallography of Syt3–SNARE complex, comparison with smFRET-derived Syt1 models","pmids":["20173763"],"confidence":"High","gaps":["Structure captured a static state; dynamics of membrane insertion not resolved","Functional relevance of the Syt3–SNARE interaction specifically (vs. Syt1) not tested in vivo"]},{"year":2013,"claim":"Demonstration that E-Syt2 and E-Syt3 constitutively tether ER to PM through PI(4,5)P₂-dependent C2 domain interactions, forming heteromeric complexes that confer Ca²⁺ regulation via E-Syt1, defined the molecular basis of E-Syt-mediated ER–PM contact sites.","evidence":"Co-immunoprecipitation, TIRF microscopy, PI(4,5)P₂ manipulation (pharmacological and genetic), Ca²⁺ imaging","pmids":["23791178"],"confidence":"High","gaps":["Relative contributions of E-Syt2 vs. E-Syt3 to tethering not individually resolved","Downstream functional consequences of tethering loss not yet identified"]},{"year":2016,"claim":"Two studies established E-Syt3's lipid transfer function and organismal dispensability: the SMP domain transfers diacylglycerol from PM to ER to maintain lipid homeostasis after PLC activation, yet triple E-Syt knockout mice are viable due to compensatory upregulation of alternative ER–PM junction proteins (Orp5/8, STIM1, Orai1).","evidence":"In vitro lipid transfer assay, E-Syt triple-KO cells with DAG biosensor and rescue experiments; triple-KO mice with gene expression analysis","pmids":["27065097","27399837"],"confidence":"High","gaps":["Individual contribution of E-Syt3 vs. E-Syt1/2 to lipid transfer not dissected","Physiological conditions that would reveal triple-KO phenotypes not identified"]},{"year":2018,"claim":"Syt3 was shown to be the postsynaptic Ca²⁺ sensor for AMPA receptor internalization: Syt3 knockout abolished GluA2 endocytosis, LTD, and LTP decay, and the TAT-GluA2-3Y peptide phenocopied and occluded the KO, establishing Syt3 as a molecular driver of forgetting.","evidence":"Syt3 KO mice, AMPA receptor internalization assay, LTD/LTP electrophysiology, TAT-GluA2-3Y peptide competition/occlusion, Morris water maze","pmids":["30545844"],"confidence":"High","gaps":["Whether Syt3 interacts directly with the endocytic machinery (AP2/clathrin) at synapses was not shown","Upstream Ca²⁺ source (NMDAR vs. VGCC) driving Syt3 activation not resolved"]},{"year":2020,"claim":"E-Syt3 was linked to diet-induced obesity via POMC neuron-specific mechanisms: its ablation enhanced POMC-to-α-MSH processing and protected against metabolic dysfunction, revealing a role for ER–PM lipid transfer in hypothalamic energy balance.","evidence":"Conditional KO (whole-body and POMC-specific), AAV overexpression in arcuate nucleus, metabolic phenotyping, PKC/AP-1 activity assays","pmids":["32747560"],"confidence":"Medium","gaps":["Precise lipid species mediating the effect on POMC processing not identified","Single lab; independent replication lacking"]},{"year":2021,"claim":"Discovery that E-Syt3 undergoes proteasome-dependent C2C domain cleavage during adipocyte differentiation and localizes truncated E-Syt3 to a primordial ER cisterna for lipid droplet biogenesis revealed a non-canonical regulation of E-Syt3 function outside the ER–PM tethering context.","evidence":"Confocal and electron microscopy/tomography, proteasome inhibition, siRNA knockdown in differentiating adipocytes","pmids":["34693607"],"confidence":"Medium","gaps":["Protease(s) responsible for cleavage not identified","Whether ER-PM tethering and lipid droplet roles are mutually exclusive not tested","Single lab"]},{"year":2023,"claim":"The Syt3–GluA2 internalization axis was shown to be pathologically co-opted during cerebral ischemia/reperfusion, where Syt3 upregulation drives GluA2 removal and Ca²⁺-permeable AMPAR formation; Syt3 KO or TAT-GluA2-3Y peptide conferred neuroprotection, nominating this interaction as a therapeutic target.","evidence":"Syt3 KO mice, MCAO model, surface biotinylation, co-IP of Syt3–GluA2, TAT-GluA2-3Y peptide, behavioral recovery assessment","pmids":["36892998"],"confidence":"High","gaps":["Cell-type specificity of Syt3 upregulation in penumbra not resolved","Therapeutic window for peptide intervention not defined"]},{"year":2025,"claim":"E-Syt3 was shown to control epithelial ion transport by extracting phosphatidylserine from ER–PM junctions via its SMP domain, antagonizing ORP5; this dissociates cAMP signaling complexes and prevents CFTR and NBCe1-B activation, establishing E-Syt3 as a lipid-dependent regulator of epithelial secretion.","evidence":"siRNA knockdown, domain deletion mutants, PtdSer biosensor, electrophysiology (CFTR/NBCe1-B currents), in vitro lipid transfer, mouse gland secretion assays","pmids":["40425857"],"confidence":"High","gaps":["Whether E-Syt3 transfers PtdSer to the same ER pool as DAG not established","Relative contribution of E-Syt3 vs. E-Syt2 in native epithelia not resolved"]},{"year":2025,"claim":"Syt3 KO exacerbated sevoflurane-induced neonatal cognitive impairment and neuroinflammation, while CRISPR-mediated Syt3 overexpression was protective, linking Syt3 to neuroprotection against anesthetic neurotoxicity beyond its role in forgetting.","evidence":"Syt3 KO mice, CRISPR activation overexpression, Western blot/ELISA for inflammatory markers, behavioral testing","pmids":["40890917"],"confidence":"Medium","gaps":["Molecular mechanism connecting Syt3 to neuroinflammation not defined","Single lab; whether effect is GluA2-dependent or independent not tested"]},{"year":null,"claim":"Major unresolved questions include: (1) how classical Syt3 and E-Syt3 functions are coordinated in cells that express both, (2) the identity of the protease(s) cleaving E-Syt3 in adipocytes, (3) whether Syt3's presynaptic role as a GABAergic Ca²⁺ sensor generalizes beyond entopeduncular terminals, and (4) the upstream Ca²⁺ source and adaptor proteins linking Syt3 to the endocytic machinery at postsynaptic sites.","evidence":"","pmids":[],"confidence":"Low","gaps":["Presynaptic Ca²⁺-sensor role from single preprint only","No structural data for E-Syt3 full-length or SMP domain","Therapeutic applicability of Syt3–GluA2 disruption peptide not validated in clinical models"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[1,5,7,15]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[7,15]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[11,14]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[3,6,13]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,6,11]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[10]},{"term_id":"GO:0005811","term_label":"lipid droplet","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[11,14,17]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[6,7,10,11]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[15]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[7,12,15]}],"complexes":["Syt3 disulfide-linked homo/heterodimer","E-Syt heteromeric complex (E-Syt1/2/3)"],"partners":["SYT5","SYT6","SYT10","ESYT1","ESYT2","STX1A","GRIA2","CXCR4"],"other_free_text":[]},"mechanistic_narrative":"SYT3 encodes synaptotagmin-3, a Ca²⁺-sensing C2-domain membrane protein that operates in two molecularly distinct contexts: as a classical synaptotagmin in neurons and immune cells, and—through its extended synaptotagmin (E-Syt3) isoform—as an ER–plasma membrane tether and lipid transfer protein. In neurons, Syt3 localizes to postsynaptic endocytic zones where it drives Ca²⁺-dependent internalization of GluA2-containing AMPA receptors, a process required for long-term depression, LTP decay, and active forgetting; the same Syt3–GluA2 interaction is pathologically engaged after ischemia/reperfusion injury to remove surface GluA2 and promote Ca²⁺-permeable AMPA receptor formation [PMID:30545844, PMID:36892998]. As E-Syt3, the protein tethers ER to PM via PI(4,5)P₂-dependent C2 domain binding and uses its SMP domain to transfer diacylglycerol and phosphatidylserine between bilayers, thereby maintaining PM lipid homeostasis and controlling cAMP-dependent epithelial ion transport through CFTR and NBCe1-B [PMID:23791178, PMID:27065097, PMID:40425857]. Syt3 forms disulfide-linked homodimers and heterodimers with other synaptotagmins via conserved N-terminal cysteines, binds syntaxin and clathrin-AP2 in a Ca²⁺-dependent manner, and in non-neuronal settings participates in CXCR4 recycling in T cells and lipid droplet biogenesis in adipocytes [PMID:10531343, PMID:7791877, PMID:17179206, PMID:34693607]."},"prefetch_data":{"uniprot":{"accession":"Q9BQG1","full_name":"Synaptotagmin-3","aliases":["Synaptotagmin III","SytIII"],"length_aa":590,"mass_kda":63.3,"function":"Ca(2+) sensor involved in Ca(2+)-dependent exocytosis of secretory vesicles through Ca(2+) and phospholipid binding to the C2 domain. Ca(2+) induces binding of the C2-domains to phospholipid membranes and to assembled SNARE-complexes; both actions contribute to triggering exocytosis (By similarity). Plays a role in dendrite formation by melanocytes (PubMed:23999003)","subcellular_location":"Cell membrane; Cytoplasmic vesicle, secretory vesicle membrane","url":"https://www.uniprot.org/uniprotkb/Q9BQG1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SYT3","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SYT3","total_profiled":1310},"omim":[{"mim_id":"604999","title":"SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 1; SHANK1","url":"https://www.omim.org/entry/604999"},{"mim_id":"600327","title":"SYNAPTOTAGMIN 3; SYT3","url":"https://www.omim.org/entry/600327"},{"mim_id":"600104","title":"SYNAPTOTAGMIN 2; SYT2","url":"https://www.omim.org/entry/600104"},{"mim_id":"600103","title":"SYNAPTOTAGMIN 4; SYT4","url":"https://www.omim.org/entry/600103"},{"mim_id":"185605","title":"SYNAPTOTAGMIN 1; SYT1","url":"https://www.omim.org/entry/185605"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":24.5}],"url":"https://www.proteinatlas.org/search/SYT3"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q9BQG1","domains":[{"cath_id":"2.60.40.150","chopping":"298-423","consensus_level":"high","plddt":92.1848,"start":298,"end":423},{"cath_id":"2.60.40.150","chopping":"432-574","consensus_level":"high","plddt":93.185,"start":432,"end":574}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BQG1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BQG1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BQG1-F1-predicted_aligned_error_v6.png","plddt_mean":68.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SYT3","jax_strain_url":"https://www.jax.org/strain/search?query=SYT3"},"sequence":{"accession":"Q9BQG1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BQG1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BQG1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BQG1"}},"corpus_meta":[{"pmid":"23791178","id":"PMC_23791178","title":"PI(4,5)P(2)-dependent and Ca(2+)-regulated ER-PM interactions mediated by the extended synaptotagmins.","date":"2013","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/23791178","citation_count":476,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20173763","id":"PMC_20173763","title":"Single-molecule FRET-derived model of the synaptotagmin 1-SNARE fusion complex.","date":"2010","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20173763","citation_count":164,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17360437","id":"PMC_17360437","title":"E-Syts, a family of membranous Ca2+-sensor proteins with multiple C2 domains.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17360437","citation_count":156,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8604041","id":"PMC_8604041","title":"Localization of synaptotagmin-binding domains on syntaxin.","date":"1996","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8604041","citation_count":141,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30545844","id":"PMC_30545844","title":"Synaptotagmin-3 drives AMPA receptor endocytosis, depression of synapse strength, and forgetting.","date":"2018","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/30545844","citation_count":104,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8058779","id":"PMC_8058779","title":"A third synaptotagmin gene, Syt3, in the mouse.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8058779","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33944955","id":"PMC_33944955","title":"Synaptotagmins at the endoplasmic reticulum-plasma membrane contact sites maintain diacylglycerol homeostasis during abiotic stress.","date":"2021","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/33944955","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28600435","id":"PMC_28600435","title":"RASSF4 controls SOCE and ER-PM junctions through regulation of PI(4,5)P2.","date":"2017","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28600435","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27399837","id":"PMC_27399837","title":"Loss of all 3 Extended Synaptotagmins does not affect normal mouse development, viability or fertility.","date":"2016","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/27399837","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21928778","id":"PMC_21928778","title":"Post-translational modifications and lipid binding profile of insect cell-expressed full-length mammalian synaptotagmin 1.","date":"2011","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21928778","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33816462","id":"PMC_33816462","title":"Identification of Biomarkers Related to CD8+ T Cell Infiltration With Gene Co-expression Network in Lung Squamous Cell Carcinoma.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33816462","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29046455","id":"PMC_29046455","title":"Extended Synaptotagmin 1 Interacts with Herpes Simplex Virus 1 Glycoprotein M and Negatively Modulates Virus-Induced Membrane Fusion.","date":"2017","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/29046455","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31046622","id":"PMC_31046622","title":"Synaptotagmins: Beyond Presynaptic Neurotransmitter Release.","date":"2019","source":"The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/31046622","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17179206","id":"PMC_17179206","title":"Synaptotagmin 3 deficiency in T cells impairs recycling of the chemokine receptor CXCR4 and thereby inhibits CXCL12 chemokine-induced migration.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/17179206","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20470891","id":"PMC_20470891","title":"Developmental expression of Synaptotagmin isoforms in single calyx of Held-generating neurons.","date":"2010","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/20470891","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32747560","id":"PMC_32747560","title":"Hypothalamic extended synaptotagmin-3 contributes to the development of dietary obesity and related metabolic disorders.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32747560","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36892998","id":"PMC_36892998","title":"Synaptotagmin-3 interactions with GluA2 mediate brain damage and impair functional recovery in stroke.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36892998","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38522078","id":"PMC_38522078","title":"Impaired neuronal macroautophagy in the prelimbic cortex contributes to comorbid anxiety-like behaviors in rats with chronic neuropathic pain.","date":"2024","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/38522078","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31190555","id":"PMC_31190555","title":"Oral administration of heat-killed Lactobacillus brevis SBC8803 elevates the ratio of acyl/des-acyl ghrelin in blood and increases short-term food intake.","date":"2019","source":"Beneficial microbes","url":"https://pubmed.ncbi.nlm.nih.gov/31190555","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37458037","id":"PMC_37458037","title":"Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.","date":"2024","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/37458037","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36777542","id":"PMC_36777542","title":"Integrated GWAS and transcriptomic analysis reveal the candidate salt-responding genes regulating Na+/K+ balance in barley (Hordeum vulgare L.).","date":"2023","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/36777542","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34693607","id":"PMC_34693607","title":"The E-Syt3 cleavage and traffic uncovers the primordial cisterna, a new organelle that mothers the lipid droplets in the adipocyte.","date":"2021","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/34693607","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35640156","id":"PMC_35640156","title":"Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4).","date":"2022","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35640156","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38844868","id":"PMC_38844868","title":"Using expression data to fine map QTL associated with fertility in dairy cattle.","date":"2024","source":"Genetics, selection, evolution : GSE","url":"https://pubmed.ncbi.nlm.nih.gov/38844868","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22933835","id":"PMC_22933835","title":"PLXNC1 and RDH13 associated with bilateral convergent strabismus with exophthalmus in German Brown cattle.","date":"2012","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/22933835","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38766439","id":"PMC_38766439","title":"Synaptotagmins family affect glucose transport in retinal pigment epithelial cells through their ubiquitination-mediated degradation and glucose transporter-1 regulation.","date":"2024","source":"World journal of diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/38766439","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40425857","id":"PMC_40425857","title":"Lipid transporters E-Syt3 and ORP5 regulate epithelial ion transport by controlling phosphatidylserine enrichment at ER/PM junctions.","date":"2025","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/40425857","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38582297","id":"PMC_38582297","title":"microRNA-2184 orchestrates Mauthner-cell axon regeneration in zebrafish via syt3 modulation.","date":"2024","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/38582297","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38069318","id":"PMC_38069318","title":"Neuronal Scaffold Protein ARMS Interacts with Synaptotagmin-4 C2AB through the Ankyrin Repeat Domain with an Unexpected Mode.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38069318","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40890917","id":"PMC_40890917","title":"Synaptotagmin III Plays a Protective Role in Neonatal Multiple Sevoflurane Exposure-Induced Cognitive Deficits in Mice.","date":"2025","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/40890917","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41195642","id":"PMC_41195642","title":"Insights Into the Antigenic Repertoire of Unclassified Synaptic Antibodies.","date":"2025","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/41195642","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40021946","id":"PMC_40021946","title":"Effects of Electroacupuncture on Syt3 and GluA2 in Rats With Limb Spasms After Intracerebral Hemorrhage.","date":"2025","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/40021946","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41959127","id":"PMC_41959127","title":"Synaptotagmin isoforms differentially regulate glutamate and GABA release in the lateral habenula.","date":"2026","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41959127","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41787472","id":"PMC_41787472","title":"Restricting Synaptotagmin-3 Internalization Mitigates Cerebral Ischemia/Reperfusion Injury by Curtailed Neuronal Apoptosis and Microglial Re-Programming.","date":"2026","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/41787472","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41796074","id":"PMC_41796074","title":"Tethers and Transporters: The Molecular Fingerprint of Plant ER-PM Contact Sites.","date":"2026","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/41796074","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11076863","id":"PMC_11076863","title":"DNA cloning using in vitro site-specific recombination.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11076863","citation_count":815,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7791877","id":"PMC_7791877","title":"Ca(2+)-dependent and -independent activities of neural and non-neural synaptotagmins.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7791877","citation_count":552,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11256614","id":"PMC_11256614","title":"Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing.","date":"2000","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/11256614","citation_count":281,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27065097","id":"PMC_27065097","title":"Control of plasma membrane lipid homeostasis by the extended synaptotagmins.","date":"2016","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27065097","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10692432","id":"PMC_10692432","title":"The C terminus of SNAP25 is essential for Ca(2+)-dependent binding of synaptotagmin to SNARE complexes.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10692432","citation_count":191,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10531343","id":"PMC_10531343","title":"Conserved N-terminal cysteine motif is essential for homo- and heterodimer formation of synaptotagmins III, V, VI, and X.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10531343","citation_count":151,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11230166","id":"PMC_11230166","title":"Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.","date":"2001","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11230166","citation_count":151,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12526776","id":"PMC_12526776","title":"Sr2+ binding to the Ca2+ binding site of the synaptotagmin 1 C2B domain triggers fast exocytosis without stimulating SNARE interactions.","date":"2003","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/12526776","citation_count":109,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10734137","id":"PMC_10734137","title":"SYNCRIP, a cytoplasmic counterpart of heterogeneous nuclear ribonucleoprotein R, interacts with ubiquitous synaptotagmin isoforms.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10734137","citation_count":83,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32814053","id":"PMC_32814053","title":"Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32814053","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11543631","id":"PMC_11543631","title":"Genomic analysis of synaptotagmin genes.","date":"2001","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11543631","citation_count":58,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"36138187","id":"PMC_36138187","title":"NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia.","date":"2022","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36138187","citation_count":46,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489336","id":"PMC_15489336","title":"From ORFeome to biology: a functional genomics pipeline.","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489336","citation_count":38,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16381901","id":"PMC_16381901","title":"The LIFEdb database in 2006.","date":"2006","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/16381901","citation_count":29,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32393512","id":"PMC_32393512","title":"SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity.","date":"2020","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/32393512","citation_count":27,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"39079530","id":"PMC_39079530","title":"Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions.","date":"2024","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/39079530","citation_count":20,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23999003","id":"PMC_23999003","title":"SYT14L, especially its C2 domain, is involved in regulating melanocyte differentiation.","date":"2013","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/23999003","citation_count":14,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35676659","id":"PMC_35676659","title":"LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.","date":"2022","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35676659","citation_count":14,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7749232","id":"PMC_7749232","title":"Synaptotagmin genes on mouse chromosomes 1, 7, and 10 and human chromosome 19.","date":"1995","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/7749232","citation_count":5,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20223,"output_tokens":3593,"usd":0.057282},"stage2":{"model":"claude-opus-4-6","input_tokens":6980,"output_tokens":3558,"usd":0.185775},"total_usd":0.568531,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":31573,"output_tokens":6705,"usd":0.097647},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9337,"output_tokens":4208,"usd":0.227827}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"Synaptotagmin-3 (Syt3) localizes to postsynaptic endocytic zones and removes AMPA receptors from synaptic plasma membranes in a calcium-sensing-dependent manner; AMPA receptor internalization, LTD, and decay of LTP were abolished in Syt3 knockout mice, and disrupting Syt3:GluA2 binding mimicked the lack of LTP decay and forgetting.\",\n      \"method\": \"Syt3 knockout mice, live imaging of postsynaptic endocytic zones, electrophysiology (LTD/LTP), spatial memory tasks, TAT-GluA2-3Y peptide to disrupt Syt3:GluA2 interaction\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KO, peptide disruption, electrophysiology, behavior) in a single study with rigorous controls\",\n      \"pmids\": [\"30545844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"E-Syt3 (extended synaptotagmin 3) is an ER-resident protein that tethers the ER to the plasma membrane via C2 domain-dependent interactions requiring PI(4,5)P2; it forms heteromeric complexes with E-Syt1 and E-Syt2 to confer cytosolic Ca2+ regulation to ER-PM contact formation, but these contacts are not required for store-operated Ca2+ entry.\",\n      \"method\": \"Co-immunoprecipitation, fluorescence microscopy of ER-PM contacts, phospholipid-binding assays, PI(4,5)P2 manipulation, Ca2+ imaging\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods replicated across labs, high citation count\",\n      \"pmids\": [\"23791178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"E-Syt3 contains three C-terminal C2 domains; its C2C domain acts as a targeting motif directing plasma membrane localization independently of the transmembrane region; the C2A domain mediates Ca2+-dependent phospholipid binding at micromolar Ca2+ concentrations.\",\n      \"method\": \"Transfection of myc-tagged constructs, domain deletion/mutation analysis, phospholipid-binding assays, immunofluorescence localization\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain mutagenesis plus biochemical and localization assays, highly cited foundational paper\",\n      \"pmids\": [\"17360437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SYT3 is required for CXCR4 recycling in T cells; loss of SYT3 function (via antisense or isolated C2B domain expression) blocks CXCR4 recycling from multivesicular bodies to the plasma membrane, reduces surface CXCR4, and impairs CXCL12-induced migration and actin polymerization without affecting adhesion.\",\n      \"method\": \"Antisense knockdown, C2B domain overexpression (oligomerization-blocking mutants), flow cytometry of surface CXCR4, migration assays, immunofluorescence localization\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (antisense, dominant-negative C2B, rescue by CXCR4 overexpression), single lab\",\n      \"pmids\": [\"17179206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The crystal structure of SNARE-induced Ca2+-bound Syt3 shows a loop arrangement in which Ca2+-binding loops point away from the SNARE complex, consistent with a model where these loops interact with the membrane; this arrangement is shared with Syt1 bound to SNAREs, suggesting a conserved mechanism for Ca2+-triggered fusion.\",\n      \"method\": \"Single-molecule FRET with 34 distance restraints, multibody docking; reference to Syt3 crystal structure with SNAREs\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — structural data (crystal structure) but cited indirectly as supporting evidence in an smFRET paper on Syt1\",\n      \"pmids\": [\"20173763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The C2AB fragment of Syt3 shows conserved lipid binding: Ca2+-independent interactions are mediated via a lysine-rich region of the C2B domain, while Ca2+-dependent interactions are mediated via the Ca2+-binding loops.\",\n      \"method\": \"Lipid binding screen with recombinant C2AB fragment of Syt3, mass spectrometry, biochemical assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical reconstitution with defined lipid panel, single lab\",\n      \"pmids\": [\"21928778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RASSF4 regulates ER-PM tethering by E-Syt2 and E-Syt3 through ARF6-dependent control of PM PI(4,5)P2 levels; RASSF4 knockdown reduces steady-state PI(4,5)P2, disrupting E-Syt3 localization at ER-PM junctions.\",\n      \"method\": \"RASSF4 knockdown, PI(4,5)P2 biosensor imaging, E-Syt3 localization by fluorescence microscopy, ARF6 co-IP\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (KD, imaging, Co-IP, lipid sensors) in single study\",\n      \"pmids\": [\"28600435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"E-Syt3, along with E-Syt1, negatively modulates HSV-1 viral release, cell-to-cell spread, viral entry, and virus-induced syncytia formation, implicating E-Syt3 as a cellular regulator of membrane fusion events during herpesvirus infection.\",\n      \"method\": \"Transfection of E-Syt3 constructs in infected and uninfected cells, viral plaque assay, syncytia quantification, viral entry assays\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional cellular assays with overexpression, single lab\",\n      \"pmids\": [\"29046455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Hypothalamic E-Syt3 (extended synaptotagmin 3) promotes diet-induced obesity; whole-body or POMC neuron-specific ablation of E-Syt3 ameliorated obesity and metabolic disorders, and E-Syt3 ablation increased processing of POMC to α-MSH by enhancing protein kinase C and AP-1 activities and expression of prohormone convertases.\",\n      \"method\": \"Conditional knockout (whole-body and POMC-specific Cre), stereotaxic viral overexpression in arcuate nucleus, metabolic phenotyping, Western blot, signaling pathway analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with molecular mechanism in multiple complementary models, single lab\",\n      \"pmids\": [\"32747560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"I/R injury augments Syt3-GluA2 protein interactions, decreases GluA2 surface expression, and promotes Ca2+-permeable AMPA receptor (CP-AMPAR) formation; Syt3 knockout mice resist cerebral ischemia with high surface GluA2 and low CP-AMPAR levels post-I/R.\",\n      \"method\": \"Co-immunoprecipitation of Syt3-GluA2, surface biotinylation, Syt3 KO mice, TAT-GluA2-3Y peptide, in vivo stroke model (MCAO)\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus KO with defined molecular phenotype, single lab\",\n      \"pmids\": [\"36892998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In differentiating adipocytes, E-Syt3 is proteolytically cleaved at its C2C domain in a proteasome-dependent multi-step mechanism; truncated E-Syt3ΔC2C and full-length E-Syt3 localize to a large annular ER cisterna ('primordial cisterna') from which lipid droplets are born; E-Syt3 knockdown inhibits lipid droplet biogenesis.\",\n      \"method\": \"Confocal and live-cell time-lapse microscopy, proteasome inhibition, electron microscopy, 3D-electron tomography, E-Syt3 knockdown\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple imaging modalities plus functional knockdown, single lab\",\n      \"pmids\": [\"34693607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"E-Syt3 functions as a lipid transfer protein that removes phosphatidylserine (PtdSer) from ER/PM junctions; this PtdSer depletion dissociates cAMP signaling complexes, prevents CFTR activation, and blocks NBCe1-B activation by IRBIT; plasma membrane localization by the C2C domain is required for this function, and E-Syt3 depletion in mice improved chloride flux and fluid secretion in salivary glands and pancreatic ducts.\",\n      \"method\": \"E-Syt3 depletion in mice, exogenous PtdSer rescue, CFTR and NBCe1-B functional assays, PtdSer sensor domain analysis, ORP5 antagonism\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — lipid transfer reconstitution, domain mutagenesis, in vivo mouse KO with functional ion transport readouts, multiple orthogonal methods\",\n      \"pmids\": [\"40425857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In zebrafish Mauthner cells, syt3 negatively regulates axon regeneration after spinal cord injury in a Ca2+-binding-dependent manner; it is a downstream target of miR-2184, and overexpression of syt3 suppresses the regeneration-promoting effect of miR-2184.\",\n      \"method\": \"Single-cell miR-2184 overexpression and sponge silencing in zebrafish M-cells, syt3 Ca2+-binding mutants, pharmacological cAMP/PKA stimulation, in vivo axon imaging\",\n      \"journal\": \"Journal of genetics and genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic manipulation in zebrafish ortholog with defined Ca2+-dependence of phenotype, single lab\",\n      \"pmids\": [\"38582297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In EPN→LHb presynaptic terminals, Syt3 selectively co-localizes with VGAT-positive (GABAergic) vesicles but not VGLUT2-positive (glutamatergic) vesicles; ASO knockdown of Syt3 in EPN neurons increases mIPSC frequency in the LHb without affecting glutamate release, identifying Syt3 as the predominant Ca2+ sensor for GABAergic vesicle fusion at dual-transmitter terminals.\",\n      \"method\": \"Confocal 3D reconstruction, antisense oligonucleotide (ASO) knockdown, miniature postsynaptic current electrophysiology (mEPSC/mIPSC)\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ASO knockdown with isoform-selective electrophysiological readout plus confocal co-localization; preprint, single lab\",\n      \"pmids\": [\"41959127\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"SYT3 is a Ca2+-sensing synaptic and ER-membrane protein with dual roles: postsynaptically, it uses Ca2+-dependent interactions with GluA2 to drive AMPA receptor endocytosis, thereby mediating LTD, LTP decay, and forgetting; presynaptically it can act as a Ca2+ sensor for GABAergic vesicle fusion; in the ER membrane it tethers the ER to the plasma membrane via PI(4,5)P2-dependent C2 domain interactions and transfers phosphatidylserine at ER-PM junctions to regulate ion channel signaling complexes (CFTR, NBCe1-B), lipid droplet biogenesis, and metabolic signaling in hypothalamic POMC neurons.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEPT papers.\n\n**Classification:**\n\n- [1] KEEP — E-Syt3 (extended synaptotagmin 3) ER-PM tethering, mammalian\n- [2] KEEP — mentions Syt3 crystal structure with SNAREs (mechanistic)\n- [3] KEEP — E-Syt family including E-Syt3 biochemical properties\n- [4] KEEP — Synaptotagmin I/syntaxin binding; fragment \"Syt3-5\" refers to domain fragments of Syt1, not SYT3 gene — EXCLUDE (alias collision, domain naming)\n- [5] KEEP — SYT3 (synaptotagmin-3) postsynaptic AMPA receptor endocytosis\n- [6] KEEP — Syt3 mouse gene identification and expression\n- [7] EXCLUDE — Arabidopsis SYT3, plant ortholog with incompatible context\n- [8] KEEP — E-Syt2 and E-Syt3 ER-PM junction formation regulated by RASSF4\n- [9] KEEP — E-Syt3 knockout mouse, no developmental phenotype\n- [10] KEEP — C2AB fragment of Syt3 lipid binding screen\n- [11] EXCLUDE — expression/biomarker study, no mechanism for SYT3\n- [12] KEEP — E-Syt3 lipid transfer at ER-PM contacts\n- [13] KEEP — review of Syt3 postsynaptic function (mechanistic summary)\n- [14] KEEP — SYT3 in T cells, CXCR4 recycling\n- [15] EXCLUDE — expression study only\n- [16] KEEP — hypothalamic E-Syt3 in diet-induced obesity, POMC processing\n- [17] KEEP — Syt3-GluA2 interaction in stroke/ischemia\n- [18] EXCLUDE — SYT3 mentioned only in abbreviation list, not mechanistic focus\n- [19] EXCLUDE — Syt3 expression correlation only\n- [20] EXCLUDE — expression/miRNA association study\n- [21] EXCLUDE — barley SYT3, plant\n- [22] KEEP — E-Syt3 cleavage in adipocytes, lipid droplet biogenesis\n- [23] EXCLUDE — Kabuki syndrome, SYT3 expression change only\n- [24] EXCLUDE — cattle eQTL association study\n- [25] EXCLUDE — cattle GWAS association\n- [26] EXCLUDE — SYT4 focus, SYT3 mentioned only as differentially expressed\n- [27] KEEP — E-Syt3 and ORP5 regulate PtdSer at ER/PM junctions, epithelial ion transport\n- [28] KEEP — zebrafish syt3 (ortholog), axon regeneration via Ca2+ binding\n- [29] KEEP — ARMS does not interact with Syt3 (negative result, mechanistic)\n- [30] KEEP — Syt3 KO mice, sevoflurane cognitive effects\n- [31] EXCLUDE — autoantibody detection study\n- [32] KEEP — Syt3/GluA2 pathway in ICH spasticity, electroacupuncture\n- [33] KEEP — Syt3 as Ca2+ sensor for GABAergic vesicle fusion in LHb (preprint)\n- [34] KEEP — Syt3 internalization inhibition in stroke\n- [35] EXCLUDE — plant review\n\n**Gene2pubmed additional papers:**\n- [8] Ca2+-dependent activities: KEEP — Syt III C2 domain phospholipid binding characterized\n- [14] Conserved N-terminal cysteine motif: KEEP — Syt III homodimerization mechanism\n- [17] SYNCRIP interacts with synaptotagmins: EXCLUDE — Syt III C2B not a binding partner per this paper (SYNCRIP binds VII, VIII, IX but not III, V, VI, X per results)\n- [13] C terminus SNAP25: EXCLUDE — focus on Syt1 binding, not SYT3\n- [16] Sr2+ binding Syt1: EXCLUDE — Syt1 focus\n- [19] Genomic analysis: KEEP — structural/genomic info on Syt3\n- Others: genomics/cDNA repositories, EXCLUDE as no mechanistic SYT3 findings\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"SYT3 (Syt3) was identified as a third member of the synaptotagmin family in mouse brain, retaining the characteristic five-domain structure (transmembrane region plus two C2 domains) of other synaptotagmins but with only ~45% amino acid identity to Syt1/Syt2 in the C2 domain. Syt3 is expressed in many regions of the nervous system but not in extraneural tissues, and in PC12 cells it is coexpressed with Syt1 at higher abundance, suggesting individual neurons may express specific synaptotagmin combinations.\",\n      \"method\": \"cDNA cloning, Northern blot, immunohistochemistry, in situ hybridization\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — original gene identification with expression mapping; single lab, multiple methods\",\n      \"pmids\": [\"8058779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The first C2 domain of Syt III (but not the C2 domain of Syt IV, VI, or VIII) binds phospholipids in a Ca2+-dependent manner with EC50 = 3–6 µM, similar to Syt I and II. Syt III also binds syntaxin in a Ca2+-dependent manner, but with a lower Ca2+ concentration dependence (<10 µM) than Syt I, II, and V (>200 µM), and all synaptotagmins tested bind clathrin-AP2 with high affinity (Kd = 0.1–1.0 nM).\",\n      \"method\": \"In vitro phospholipid-binding assay, Ca2+-dependent syntaxin binding assay, clathrin-AP2 binding assay\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical reconstitution with quantitative Ca2+ dependence; replicated across multiple synaptotagmin isoforms in same study\",\n      \"pmids\": [\"7791877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Syt III forms beta-mercaptoethanol-sensitive homodimers and heterodimers with Syt V, VI, and X via three conserved N-terminal cysteine residues (C10, C21, C33 in mouse Syt III). Site-directed mutagenesis showed that the first cysteine (C10) is essential for stable homodimer formation of Syt III, V, and VI, and for heterodimer formation among Syt III, V, VI, and X. Native Syt III from mouse brain also forms these disulfide-linked homodimers.\",\n      \"method\": \"Site-directed mutagenesis, co-immunoprecipitation, SDS-PAGE under reducing/non-reducing conditions, native brain protein analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with co-IP and native brain validation; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"10531343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"E-Syt3 (extended synaptotagmin-3) is an ER-resident transmembrane protein with three C-terminal C2 domains. Its C2C domain (the most C-terminal C2 domain) functions as a targeting motif directing E-Syt3 to the plasma membrane independently of its transmembrane region. E-Syt2 and E-Syt3 localize to the plasma membrane in transfected cells, unlike E-Syt1 which localizes to intracellular membranes.\",\n      \"method\": \"Transfection of myc-tagged constructs, immunofluorescence microscopy, domain deletion analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional domain mapping; single lab\",\n      \"pmids\": [\"17360437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The crystal structure of Ca2+-bound Syt3 in complex with the SNARE complex was determined and revealed that the Ca2+-binding loops of Syt3 point away from the SNARE complex, suggesting they may interact with the same membrane. This loop arrangement is similar to that inferred from smFRET-derived models of the Syt1-SNARE complex, supporting a conserved mechanism by which synaptotagmin-SNARE interaction aids Ca2+-triggered fusion.\",\n      \"method\": \"X-ray crystallography (crystal structure of SNARE-induced Ca2+-bound Syt3), single-molecule FRET\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure determination with functional implications; structural data from Syt3 directly cited\",\n      \"pmids\": [\"20173763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A lipid-binding screen using the C2AB fragment of Syt3 revealed Ca2+-independent lipid interactions mediated via a lysine-rich region of the C2B domain and Ca2+-dependent interactions via the Ca2+-binding loops, consistent with a conserved lipid-binding mechanism shared with Syt1.\",\n      \"method\": \"Lipid binding screen (protein-lipid overlay and liposome binding assays) with recombinant C2AB fragments, mass spectrometry\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro lipid binding assay; single lab, single study\",\n      \"pmids\": [\"21928778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"E-Syt2 and E-Syt3 function as ER-PM tethers through C2 domain-dependent interactions with the plasma membrane that require PI(4,5)P2. E-Syts form heteromeric complexes with each other, and through this heterodimerization, E-Syt1 (which also requires elevated cytosolic Ca2+) confers Ca2+ regulation to ER-PM contact formation. E-Syt-dependent contacts are functionally distinct from STIM1/Orai1-mediated contacts and are not required for store-operated Ca2+ entry.\",\n      \"method\": \"Co-immunoprecipitation, fluorescence microscopy, PI(4,5)P2 manipulation (pharmacological and genetic), Ca2+ imaging, TIRF microscopy\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, replicated across conditions; highly cited foundational study\",\n      \"pmids\": [\"23791178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"E-Syt3 (along with E-Syt1 and E-Syt2) transfers glycerolipids between bilayers in vitro in a Ca2+-dependent manner requiring their SMP domain. Cells lacking all E-Syts show enhanced and sustained accumulation of plasma membrane diacylglycerol following PLC activation (PtdIns(4,5)P2 hydrolysis), demonstrating that E-Syts participate in homeostatic control of PM lipid composition by transferring diacylglycerol from the PM to the ER for metabolic recycling.\",\n      \"method\": \"In vitro lipid transfer assay, genome-edited E-Syt knockout cells, diacylglycerol imaging (DAG biosensor), rescue experiments with SMP-domain mutants\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro lipid transfer plus KO cell rescue with domain mutagenesis; multiple orthogonal approaches\",\n      \"pmids\": [\"27065097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Combined inactivation of all three E-Syt genes (E-Syt1, 2, and 3) in mice does not affect viability, fertility, or development under laboratory conditions, but induces compensatory upregulation of Orp5/8, Orai1, STIM1, and TMEM110 genes encoding other ER-PM junction proteins.\",\n      \"method\": \"Triple knockout mouse generation (insertion/deletion mutations), phenotypic analysis, gene expression analysis\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined phenotypic readout and compensatory gene expression analysis; single lab\",\n      \"pmids\": [\"27399837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RASSF4 regulates the ER-PM tethering function of E-Syt2 and E-Syt3 by controlling steady-state PM PI(4,5)P2 levels through ARF6-dependent regulation of type I PIP5Ks. RASSF4 knockdown reduces PM PI(4,5)P2, which is required for E-Syt2/3 localization at ER-PM junctions.\",\n      \"method\": \"siRNA knockdown, PI(4,5)P2 biosensor imaging, TIRF microscopy, RASSF4-ARF6 interaction analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with biosensor imaging; single lab\",\n      \"pmids\": [\"28600435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SYT3 is the only synaptotagmin expressed in T cells. SYT3 localizes predominantly to multivesicular bodies (not the plasma membrane) where it colocalizes with CXCR4. Knockdown of SYT3 by antisense mRNA or blockade by the isolated C2B domain (which impairs oligomerization) inhibits CXCR4 recycling back to the cell surface, reduces surface CXCR4 levels, and consequently inhibits CXCL12-induced T cell migration and actin polymerization. Overexpression of CXCR4 rescues migration, confirming the mechanism is through receptor recycling.\",\n      \"method\": \"Antisense mRNA knockdown, C2B domain overexpression, immunofluorescence microscopy, flow cytometry (surface CXCR4), chemotaxis assay, actin polymerization assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with defined phenotypic readout and rescue experiment; single lab, multiple readouts\",\n      \"pmids\": [\"17179206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Syt3 localizes to postsynaptic endocytic zones in neurons and removes AMPA receptors (specifically GluA2-containing) from synaptic plasma membranes in a Ca2+-dependent manner in response to stimulation. Syt3 knockout abolishes AMPA receptor internalization, long-term depression (LTD), and decay of long-term potentiation (LTP). Disrupting the Syt3:GluA2 interaction using a TAT-GluA2-3Y peptide mimics the Syt3 KO phenotype (lack of LTP decay and lack of forgetting in spatial memory tasks), and these effects are occluded in the Syt3 KO, confirming direct mechanistic linkage.\",\n      \"method\": \"Syt3 knockout mice, immunofluorescence localization, AMPA receptor internalization assay, LTD and LTP electrophysiology, TAT-GluA2-3Y peptide competition, Morris water maze and spatial memory tasks\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO plus peptide competition with occlusion experiment plus multiple behavioral and electrophysiological readouts; single lab but highly rigorous multi-method study\",\n      \"pmids\": [\"30545844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Hypothalamic E-Syt3 (extended synaptotagmin-3) contributes to diet-induced obesity. Whole-body or POMC neuron-specific ablation of E-Syt3 ameliorates diet-induced obesity, glucose intolerance, and dyslipidemia. Mechanistically, E-Syt3 ablation leads to increased processing of POMC to α-MSH, increased PKC and AP-1 activities, and enhanced expression of prohormone convertases. Conversely, E-Syt3 overexpression in the arcuate nucleus promotes food intake and impairs energy expenditure.\",\n      \"method\": \"Conditional KO (whole-body and POMC-neuron-specific), AAV-mediated overexpression, Western blot, ELISA, metabolic phenotyping, kinase activity assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with cell-type specificity and molecular mechanism identified; single lab\",\n      \"pmids\": [\"32747560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In differentiating adipocytes, E-Syt3 undergoes proteolytic cleavage of its C-terminal C2C domain by a proteasome-dependent multi-step mechanism. Truncated E-Syt3ΔC2C and endogenous E-Syt3 localize to a specialized ER cisterna (termed the 'primordial cisterna') that serves as the birth site of lipid droplets. Knockdown of E-Syt3 inhibits lipid droplet biogenesis in adipocytes.\",\n      \"method\": \"Confocal microscopy, live-cell time-lapse imaging, proteasome inhibition, siRNA knockdown, electron microscopy, 3D electron tomography\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional consequence (KD phenotype) and structural imaging; single lab\",\n      \"pmids\": [\"34693607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Syt3 is upregulated in the penumbra after ischemia/reperfusion injury. Mechanistically, I/R injury augments Syt3-GluA2 interactions, decreases GluA2 surface expression, and promotes formation of Ca2+-permeable AMPA receptors (CP-AMPARs). Syt3 knockout mice are resistant to cerebral ischemia due to high surface GluA2 and low CP-AMPAR levels. Disrupting Syt3-GluA2 binding via TAT-GluA2-3Y peptide promotes recovery from neurological impairments.\",\n      \"method\": \"Syt3 KO mice, siRNA knockdown/overexpression, co-immunoprecipitation (Syt3-GluA2), surface biotinylation assay, TAT-GluA2-3Y peptide, MCAO model, behavioral testing\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO plus co-IP plus peptide disruption with multiple functional readouts; mechanistically orthogonal approaches\",\n      \"pmids\": [\"36892998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"E-Syt3 controls epithelial ion transport by transferring phosphatidylserine (PtdSer) away from ER/PM junction nanodomains, acting antagonistically to ORP5 (which supplies PtdSer). Removal of PtdSer from junctions by E-Syt3 dissociates the cAMP signaling complex, preventing CFTR chloride channel activation and blocking NBCe1-B activation by IRBIT. The C2C domain of E-Syt3 restricts its localization to ER/PM junctions, and lipid transfer activity requires the SMP domain. E-Syt3 depletion in mice improves chloride flux and fluid secretion in salivary glands and pancreatic ducts.\",\n      \"method\": \"SiRNA knockdown, domain deletion mutants, PtdSer biosensor, co-immunoprecipitation, electrophysiology (CFTR and NBCe1-B currents), mouse gland secretion assays, in vitro lipid transfer\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — lipid transfer reconstitution combined with KD, domain mutagenesis, electrophysiology, and in vivo mouse assays; multiple orthogonal methods\",\n      \"pmids\": [\"40425857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In zebrafish Mauthner cells, syt3 (ortholog of mammalian SYT3) negatively regulates axon regeneration after spinal cord injury, and this suppression depends on Ca2+ binding by Syt3. MicroRNA-2184 promotes axon regeneration by repressing syt3 expression. Pharmacological stimulation of the cAMP/PKA pathway suggests changes in the readily releasable pool may underlie the Syt3-dependent suppression of regeneration.\",\n      \"method\": \"Single M-cell miR-2184 overexpression/sponge silencing, syt3 knockdown/overexpression in zebrafish, Ca2+-binding mutant analysis, cAMP/PKA pathway pharmacology, axon regeneration imaging\",\n      \"journal\": \"Journal of genetics and genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ortholog in zebrafish with Ca2+-binding mutant validation and pharmacological epistasis; single lab\",\n      \"pmids\": [\"38582297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Syt3 knockout mice exposed to neonatal sevoflurane show exacerbated cognitive impairment, increased neuroinflammation (IL-1β, TNF-α, MCP-1), and increased anxiety-like behavior compared to WT mice. Conversely, CRISPR-mediated Syt3 overexpression in WT mice mitigates sevoflurane-induced cognitive deficits and neuroinflammation. Sevoflurane exposure itself reduces hippocampal Syt3 protein levels in WT mice.\",\n      \"method\": \"Syt3 KO mice, CRISPR activation overexpression, Western blot/ELISA for Syt3 and inflammatory markers, object location memory, novel object recognition, elevated plus maze\",\n      \"journal\": \"ACS chemical neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO and overexpression with defined behavioral and molecular readouts; single lab\",\n      \"pmids\": [\"40890917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In EPN neurons projecting to the lateral habenula, Syt3 is highly expressed and selectively co-localizes with VGAT (GABAergic vesicle marker) rather than VGLUT2, and antisense oligonucleotide knockdown of Syt3 increases mIPSC frequency (quantal GABA release probability) without affecting glutamate release, establishing Syt3 as the predominant Ca2+ sensor for GABAergic vesicle fusion at these dual-transmitter terminals.\",\n      \"method\": \"Confocal 3D reconstruction, antisense oligonucleotide knockdown, whole-cell patch-clamp electrophysiology (mEPSC and mIPSC recording)\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ASO KD with electrophysiological functional readout; preprint, single lab\",\n      \"pmids\": [\"41959127\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"SYT3 (synaptotagmin-3) is a Ca2+-sensing membrane protein that functions in multiple cellular contexts: in neurons, it acts postsynaptically as a Ca2+-dependent driver of AMPA receptor (GluA2) endocytosis at endocytic zones, thereby mediating LTD, LTP decay, and forgetting, while presynaptically it serves as a Ca2+ sensor for GABAergic vesicle fusion; as an extended synaptotagmin (E-Syt3), it tethers the ER to the plasma membrane via PI(4,5)P2-dependent C2 domain interactions, transfers phosphatidylserine and diacylglycerol between membranes through its SMP domain to maintain PM lipid homeostasis and control epithelial ion transport, and undergoes proteasome-dependent cleavage in adipocytes to support lipid droplet biogenesis; additionally, SYT3 forms disulfide-linked homodimers and heterodimers with other synaptotagmins via conserved N-terminal cysteine residues, and in T cells it localizes to multivesicular bodies where it is required for CXCR4 recycling and chemokine-directed migration.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SYT3 encodes two distinct gene products—synaptotagmin-3 (Syt3) and extended synaptotagmin-3 (E-Syt3)—that function as Ca²⁺-sensing membrane proteins governing receptor trafficking, membrane contact site formation, and lipid transfer. Syt3 drives Ca²⁺-dependent AMPA receptor internalization at postsynaptic endocytic zones through direct interaction with GluA2, a mechanism essential for LTD, LTP decay, and forgetting, and whose dysregulation after ischemia–reperfusion injury promotes excitotoxic Ca²⁺-permeable AMPA receptor formation [PMID:30545844, PMID:36892998]. E-Syt3 is an ER-anchored protein whose C2C domain targets it to the plasma membrane in a PI(4,5)P₂-dependent manner to tether ER–PM contact sites; it transfers phosphatidylserine away from these junctions, thereby dissociating cAMP signaling complexes and negatively regulating CFTR and NBCe1-B ion channel activity [PMID:23791178, PMID:40425857]. E-Syt3 additionally localizes to primordial ER cisternae to promote lipid droplet biogenesis in adipocytes and, in hypothalamic POMC neurons, promotes diet-induced obesity by suppressing POMC processing to α-MSH [PMID:34693607, PMID:32747560].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Whether Syt3 participates in membrane trafficking beyond neurotransmitter release was unknown; demonstration that Syt3 is required for CXCR4 recycling from multivesicular bodies in T cells established a non-neuronal, endosomal trafficking role.\",\n      \"evidence\": \"Antisense knockdown and dominant-negative C2B domain expression in T cells with flow cytometry and migration assays\",\n      \"pmids\": [\"17179206\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; no independent replication\", \"Mechanism of Syt3 action on MVB-to-PM recycling undefined\", \"Relevance to neuronal Syt3 function not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The domain architecture of E-Syt3 was uncharacterized; mapping of its three C2 domains showed that C2C independently targets the plasma membrane while C2A mediates Ca²⁺-dependent phospholipid binding, defining the modular logic of E-Syt3 membrane engagement.\",\n      \"evidence\": \"Domain deletion/mutation constructs, phospholipid-binding assays, and immunofluorescence in transfected cells\",\n      \"pmids\": [\"17360437\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Lipid specificity of C2C binding not fully resolved\", \"In vivo significance of individual domains untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"How Syt3 C2 domains orient relative to SNAREs and membranes during fusion was unclear; a crystal structure of SNARE-complexed Ca²⁺-bound Syt3 revealed that Ca²⁺-binding loops face away from the SNARE complex toward the membrane, supporting a conserved fusogenic mechanism shared with Syt1.\",\n      \"evidence\": \"Crystal structure of Syt3–SNARE complex, referenced with smFRET distance restraints\",\n      \"pmids\": [\"20173763\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structure discussed in context of Syt1; independent validation of Syt3-specific contacts limited\", \"No functional mutagenesis confirming loop–membrane insertion for Syt3\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The lipid-binding repertoire of Syt3's tandem C2 domains was undefined; biochemical screening showed that C2B binds membranes Ca²⁺-independently via a polybasic region while Ca²⁺-binding loops mediate regulated lipid engagement, paralleling but extending Syt1 biochemistry.\",\n      \"evidence\": \"Recombinant C2AB fragment lipid-binding screen and mass spectrometry\",\n      \"pmids\": [\"21928778\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vitro system only; cellular membrane context not tested\", \"Quantitative affinity comparisons with other synaptotagmin isoforms incomplete\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Whether E-Syt3 functioned at ER–PM contact sites was unknown; demonstration that E-Syt3 tethers the ER to the PM via PI(4,5)P₂-dependent C2 domain interactions and forms heteromeric complexes with E-Syt1/2 established E-Syt3 as a core ER–PM tethering protein regulated by cytosolic Ca²⁺.\",\n      \"evidence\": \"Co-immunoprecipitation, fluorescence microscopy of ER–PM contacts, PI(4,5)P₂ manipulation, and Ca²⁺ imaging\",\n      \"pmids\": [\"23791178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Lipid transfer activity not yet demonstrated\", \"Physiological requirement in vivo not addressed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The upstream regulation of E-Syt3 tethering was undefined; identification of RASSF4-ARF6-dependent control of PM PI(4,5)P₂ as necessary for E-Syt3 localization at ER–PM junctions linked small GTPase signaling to contact site maintenance, while concurrent work showed E-Syt3 negatively modulates HSV-1 membrane fusion events.\",\n      \"evidence\": \"RASSF4 knockdown with PI(4,5)P₂ biosensors and E-Syt3 imaging; viral plaque and entry assays with E-Syt3 overexpression\",\n      \"pmids\": [\"28600435\", \"29046455\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct physical interaction between RASSF4 and E-Syt3 not shown\", \"Antiviral mechanism unclear—overexpression only, no KO\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Whether any synaptotagmin isoform drove postsynaptic AMPA receptor removal was an open question; Syt3 knockout mice revealed that Syt3 localizes to postsynaptic endocytic zones and is essential for Ca²⁺-dependent GluA2-containing AMPA receptor internalization, LTD, LTP decay, and spatial forgetting.\",\n      \"evidence\": \"Syt3 knockout mice, live imaging, electrophysiology, spatial memory tasks, TAT-GluA2-3Y peptide disruption\",\n      \"pmids\": [\"30545844\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endocytic adaptor linking Syt3 to clathrin machinery unknown\", \"Whether Syt3 similarly regulates other AMPAR subunits untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"A metabolic function for E-Syt3 was unsuspected; POMC neuron-specific ablation of E-Syt3 ameliorated diet-induced obesity by enhancing PKC/AP-1 signaling and prohormone convertase expression, establishing E-Syt3 as a negative regulator of POMC processing to α-MSH in hypothalamic energy homeostasis.\",\n      \"evidence\": \"Whole-body and POMC-Cre conditional knockout mice, stereotaxic viral rescue, metabolic phenotyping, Western blot\",\n      \"pmids\": [\"32747560\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Lipid transfer mechanism underlying PKC/AP-1 activation not defined\", \"Single lab; no independent replication\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Whether E-Syt3 participated in organelle biogenesis was unknown; discovery that E-Syt3 localizes to a primordial ER cisterna and is proteolytically cleaved at its C2C domain during adipocyte differentiation, with knockdown blocking lipid droplet formation, revealed a role in lipid droplet biogenesis.\",\n      \"evidence\": \"Confocal/live-cell microscopy, 3D electron tomography, proteasome inhibition, E-Syt3 knockdown in differentiating adipocytes\",\n      \"pmids\": [\"34693607\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of protease(s) performing C2C cleavage unknown\", \"Whether cleavage is required or merely coincident with LD biogenesis not resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Whether Syt3-mediated AMPAR internalization contributed to ischemic pathology was untested; demonstration that ischemia–reperfusion augments Syt3–GluA2 interaction, reduces surface GluA2, and promotes Ca²⁺-permeable AMPAR formation—with Syt3 KO mice being protected—extended the forgetting mechanism to excitotoxic injury.\",\n      \"evidence\": \"Co-immunoprecipitation, surface biotinylation, Syt3 KO mice, MCAO stroke model, TAT-GluA2-3Y peptide\",\n      \"pmids\": [\"36892998\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Therapeutic window for Syt3 inhibition in stroke not defined\", \"Downstream signaling from CP-AMPARs in this context not fully characterized\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"A role for Syt3 in axon regeneration was unknown; zebrafish studies showed that syt3 negatively regulates axon regeneration in Mauthner cells downstream of miR-2184 in a Ca²⁺-binding-dependent manner, linking Syt3 membrane activity to regenerative failure.\",\n      \"evidence\": \"Single-cell miR-2184 manipulation, syt3 Ca²⁺-binding mutants, cAMP/PKA pharmacology, in vivo axon imaging in zebrafish\",\n      \"pmids\": [\"38582297\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which Syt3 suppresses regeneration (trafficking vs. signaling) unresolved\", \"Mammalian relevance not tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Whether E-Syt3 actively transfers lipids in vivo was unresolved; identification of E-Syt3 as a phosphatidylserine transfer protein that depletes PtdSer from ER–PM junctions to dissociate cAMP signaling complexes, thereby inhibiting CFTR and NBCe1-B, provided the first direct link between E-Syt3 lipid transfer and ion channel regulation.\",\n      \"evidence\": \"E-Syt3 KO mice, exogenous PtdSer rescue, CFTR/NBCe1-B functional assays, PtdSer sensor analysis, ORP5 antagonism\",\n      \"pmids\": [\"40425857\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of PtdSer transfer by E-Syt3 not determined\", \"Whether PtdSer transfer explains all E-Syt3 metabolic phenotypes (obesity, lipid droplets) is unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of E-Syt3 lipid transfer, the identity of adaptors linking Syt3 to postsynaptic endocytic machinery, whether PtdSer transfer accounts for E-Syt3's roles in obesity and lipid droplet biogenesis, and the presynaptic sensor function of Syt3 in mammalian GABAergic terminals.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No reconstituted lipid transfer structural data\", \"Endocytic adaptor for postsynaptic Syt3 unknown\", \"Presynaptic Ca²⁺-sensor role only shown in one preprint\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [1, 2, 5, 11]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [0, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 10, 11]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2, 3, 6]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 9]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [8, 10]}\n    ],\n    \"complexes\": [\n      \"E-Syt1/E-Syt2/E-Syt3 heteromeric complex\"\n    ],\n    \"partners\": [\n      \"GRIA2\",\n      \"ESYT1\",\n      \"ESYT2\",\n      \"CXCR4\",\n      \"CFTR\",\n      \"SLC4A7\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"SYT3 encodes synaptotagmin-3, a Ca²⁺-sensing C2-domain membrane protein that operates in two molecularly distinct contexts: as a classical synaptotagmin in neurons and immune cells, and—through its extended synaptotagmin (E-Syt3) isoform—as an ER–plasma membrane tether and lipid transfer protein. In neurons, Syt3 localizes to postsynaptic endocytic zones where it drives Ca²⁺-dependent internalization of GluA2-containing AMPA receptors, a process required for long-term depression, LTP decay, and active forgetting; the same Syt3–GluA2 interaction is pathologically engaged after ischemia/reperfusion injury to remove surface GluA2 and promote Ca²⁺-permeable AMPA receptor formation [PMID:30545844, PMID:36892998]. As E-Syt3, the protein tethers ER to PM via PI(4,5)P₂-dependent C2 domain binding and uses its SMP domain to transfer diacylglycerol and phosphatidylserine between bilayers, thereby maintaining PM lipid homeostasis and controlling cAMP-dependent epithelial ion transport through CFTR and NBCe1-B [PMID:23791178, PMID:27065097, PMID:40425857]. Syt3 forms disulfide-linked homodimers and heterodimers with other synaptotagmins via conserved N-terminal cysteines, binds syntaxin and clathrin-AP2 in a Ca²⁺-dependent manner, and in non-neuronal settings participates in CXCR4 recycling in T cells and lipid droplet biogenesis in adipocytes [PMID:10531343, PMID:7791877, PMID:17179206, PMID:34693607].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Identification of Syt3 as a third synaptotagmin family member with the conserved five-domain architecture but distinct brain-region expression patterns established that individual neurons likely deploy specific synaptotagmin combinations.\",\n      \"evidence\": \"cDNA cloning, Northern blot, immunohistochemistry, and in situ hybridization in mouse brain and PC12 cells\",\n      \"pmids\": [\"8058779\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional data; expression pattern alone does not reveal isoform-specific roles\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Biochemical characterization revealed that Syt3's first C2 domain binds phospholipids and syntaxin in a Ca²⁺-dependent manner (EC₅₀ 3–6 µM), with a lower Ca²⁺ threshold for syntaxin binding than Syt1/2, and that all synaptotagmins bind clathrin-AP2 at nanomolar affinity—establishing Syt3 as a Ca²⁺ sensor with potential roles in both fusion and endocytosis.\",\n      \"evidence\": \"In vitro phospholipid-binding, syntaxin-binding, and clathrin-AP2 binding assays with purified recombinant domains\",\n      \"pmids\": [\"7791877\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"All data from in vitro assays; cellular context for syntaxin vs. AP2 engagement unknown\", \"Functional consequence of lower Ca²⁺ threshold not tested in cells\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Discovery that Syt3 forms disulfide-linked homodimers and heterodimers with Syt V/VI/X via conserved N-terminal cysteines (C10 essential) revealed an oligomerization mechanism that could diversify Ca²⁺-sensing complexes.\",\n      \"evidence\": \"Site-directed mutagenesis, co-immunoprecipitation, non-reducing SDS-PAGE of recombinant and native mouse brain protein\",\n      \"pmids\": [\"10531343\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional significance of homo- vs. heterodimer pools in vivo unknown\", \"Stoichiometry and dynamics of native complexes not resolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"SYT3 was identified as the sole synaptotagmin in T cells, localizing to multivesicular bodies where it controls CXCR4 recycling to the surface; its knockdown impaired chemokine-directed migration, broadening Syt3 function beyond neurons to immune cell trafficking.\",\n      \"evidence\": \"Antisense knockdown, C2B domain overexpression, flow cytometry for surface CXCR4, chemotaxis assay, CXCR4 overexpression rescue in T cells\",\n      \"pmids\": [\"17179206\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Antisense knockdown lacks specificity controls of modern siRNA/KO approaches\", \"Direct physical interaction between Syt3 and CXCR4 not demonstrated\", \"Whether the recycling role is C2 domain Ca²⁺-dependent was not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Characterization of E-Syt3 as an ER-resident protein whose C2C domain targets it to the PM established a distinct extended-synaptotagmin identity and began to separate E-Syt biology from classical synaptotagmin function.\",\n      \"evidence\": \"Myc-tagged domain deletion constructs, immunofluorescence microscopy in transfected cells\",\n      \"pmids\": [\"17360437\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Overexpression system; endogenous localization not validated\", \"Lipid-binding specificity of C2C domain not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The crystal structure of Ca²⁺-bound Syt3 in complex with the SNARE complex showed that Ca²⁺-binding loops face away from the SNARE bundle, consistent with simultaneous membrane and SNARE engagement—providing a structural framework for Ca²⁺-triggered fusion.\",\n      \"evidence\": \"X-ray crystallography of Syt3–SNARE complex, comparison with smFRET-derived Syt1 models\",\n      \"pmids\": [\"20173763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure captured a static state; dynamics of membrane insertion not resolved\", \"Functional relevance of the Syt3–SNARE interaction specifically (vs. Syt1) not tested in vivo\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstration that E-Syt2 and E-Syt3 constitutively tether ER to PM through PI(4,5)P₂-dependent C2 domain interactions, forming heteromeric complexes that confer Ca²⁺ regulation via E-Syt1, defined the molecular basis of E-Syt-mediated ER–PM contact sites.\",\n      \"evidence\": \"Co-immunoprecipitation, TIRF microscopy, PI(4,5)P₂ manipulation (pharmacological and genetic), Ca²⁺ imaging\",\n      \"pmids\": [\"23791178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of E-Syt2 vs. E-Syt3 to tethering not individually resolved\", \"Downstream functional consequences of tethering loss not yet identified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Two studies established E-Syt3's lipid transfer function and organismal dispensability: the SMP domain transfers diacylglycerol from PM to ER to maintain lipid homeostasis after PLC activation, yet triple E-Syt knockout mice are viable due to compensatory upregulation of alternative ER–PM junction proteins (Orp5/8, STIM1, Orai1).\",\n      \"evidence\": \"In vitro lipid transfer assay, E-Syt triple-KO cells with DAG biosensor and rescue experiments; triple-KO mice with gene expression analysis\",\n      \"pmids\": [\"27065097\", \"27399837\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual contribution of E-Syt3 vs. E-Syt1/2 to lipid transfer not dissected\", \"Physiological conditions that would reveal triple-KO phenotypes not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Syt3 was shown to be the postsynaptic Ca²⁺ sensor for AMPA receptor internalization: Syt3 knockout abolished GluA2 endocytosis, LTD, and LTP decay, and the TAT-GluA2-3Y peptide phenocopied and occluded the KO, establishing Syt3 as a molecular driver of forgetting.\",\n      \"evidence\": \"Syt3 KO mice, AMPA receptor internalization assay, LTD/LTP electrophysiology, TAT-GluA2-3Y peptide competition/occlusion, Morris water maze\",\n      \"pmids\": [\"30545844\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Syt3 interacts directly with the endocytic machinery (AP2/clathrin) at synapses was not shown\", \"Upstream Ca²⁺ source (NMDAR vs. VGCC) driving Syt3 activation not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"E-Syt3 was linked to diet-induced obesity via POMC neuron-specific mechanisms: its ablation enhanced POMC-to-α-MSH processing and protected against metabolic dysfunction, revealing a role for ER–PM lipid transfer in hypothalamic energy balance.\",\n      \"evidence\": \"Conditional KO (whole-body and POMC-specific), AAV overexpression in arcuate nucleus, metabolic phenotyping, PKC/AP-1 activity assays\",\n      \"pmids\": [\"32747560\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Precise lipid species mediating the effect on POMC processing not identified\", \"Single lab; independent replication lacking\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Discovery that E-Syt3 undergoes proteasome-dependent C2C domain cleavage during adipocyte differentiation and localizes truncated E-Syt3 to a primordial ER cisterna for lipid droplet biogenesis revealed a non-canonical regulation of E-Syt3 function outside the ER–PM tethering context.\",\n      \"evidence\": \"Confocal and electron microscopy/tomography, proteasome inhibition, siRNA knockdown in differentiating adipocytes\",\n      \"pmids\": [\"34693607\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Protease(s) responsible for cleavage not identified\", \"Whether ER-PM tethering and lipid droplet roles are mutually exclusive not tested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The Syt3–GluA2 internalization axis was shown to be pathologically co-opted during cerebral ischemia/reperfusion, where Syt3 upregulation drives GluA2 removal and Ca²⁺-permeable AMPAR formation; Syt3 KO or TAT-GluA2-3Y peptide conferred neuroprotection, nominating this interaction as a therapeutic target.\",\n      \"evidence\": \"Syt3 KO mice, MCAO model, surface biotinylation, co-IP of Syt3–GluA2, TAT-GluA2-3Y peptide, behavioral recovery assessment\",\n      \"pmids\": [\"36892998\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type specificity of Syt3 upregulation in penumbra not resolved\", \"Therapeutic window for peptide intervention not defined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"E-Syt3 was shown to control epithelial ion transport by extracting phosphatidylserine from ER–PM junctions via its SMP domain, antagonizing ORP5; this dissociates cAMP signaling complexes and prevents CFTR and NBCe1-B activation, establishing E-Syt3 as a lipid-dependent regulator of epithelial secretion.\",\n      \"evidence\": \"siRNA knockdown, domain deletion mutants, PtdSer biosensor, electrophysiology (CFTR/NBCe1-B currents), in vitro lipid transfer, mouse gland secretion assays\",\n      \"pmids\": [\"40425857\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether E-Syt3 transfers PtdSer to the same ER pool as DAG not established\", \"Relative contribution of E-Syt3 vs. E-Syt2 in native epithelia not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Syt3 KO exacerbated sevoflurane-induced neonatal cognitive impairment and neuroinflammation, while CRISPR-mediated Syt3 overexpression was protective, linking Syt3 to neuroprotection against anesthetic neurotoxicity beyond its role in forgetting.\",\n      \"evidence\": \"Syt3 KO mice, CRISPR activation overexpression, Western blot/ELISA for inflammatory markers, behavioral testing\",\n      \"pmids\": [\"40890917\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism connecting Syt3 to neuroinflammation not defined\", \"Single lab; whether effect is GluA2-dependent or independent not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include: (1) how classical Syt3 and E-Syt3 functions are coordinated in cells that express both, (2) the identity of the protease(s) cleaving E-Syt3 in adipocytes, (3) whether Syt3's presynaptic role as a GABAergic Ca²⁺ sensor generalizes beyond entopeduncular terminals, and (4) the upstream Ca²⁺ source and adaptor proteins linking Syt3 to the endocytic machinery at postsynaptic sites.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Presynaptic Ca²⁺-sensor role from single preprint only\", \"No structural data for E-Syt3 full-length or SMP domain\", \"Therapeutic applicability of Syt3–GluA2 disruption peptide not validated in clinical models\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [1, 5, 7, 15]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [7, 15]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [11, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [3, 6, 13]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 6, 11]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0005811\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [11, 14, 17]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [6, 7, 10, 11]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [7, 12, 15]}\n    ],\n    \"complexes\": [\n      \"Syt3 disulfide-linked homo/heterodimer\",\n      \"E-Syt heteromeric complex (E-Syt1/2/3)\"\n    ],\n    \"partners\": [\n      \"SYT5\",\n      \"SYT6\",\n      \"SYT10\",\n      \"ESYT1\",\n      \"ESYT2\",\n      \"STX1A\",\n      \"GRIA2\",\n      \"CXCR4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}